Brazil's Diagnostic Imaging Boom: Navigating Market Entry After ANVISA's 2024 Regulatory Shift

This episode explores Brazil's rapidly growing diagnostic imaging market, a key area for global MedTech companies like Philips Healthcare. We analyze the market's projected growth to USD 1.73 billion by 2030, the primary drivers behind this expansion, and the significant impact of ANVISA's June 2024 regulatory changes, which now recognize approvals from the US, Canada, Japan, and Australia. The discussion covers the opportunities and persistent challenges, such as import dependency and the demand for digital and portable imaging solutions in this dynamic Latin American market. - Why is Brazil's diagnostic imaging market set to grow at over 5.6% annually? - How does ANVISA's June 2024 mutual recognition agreement impact device registration times? - What are the main drivers for imaging equipment demand in Brazil? - Which challenges do foreign manufacturers face when entering the Brazilian market? - What opportunities exist for companies specializing in portable and AI-driven imaging devices? - How are major players like Philips and Siemens adapting to local market needs? - What role does digital transformation play in Brazil's healthcare system? Pure Global offers expert, end-to-end regulatory consulting to help MedTech and IVD companies navigate complex markets like Brazil. By combining local expertise with advanced AI tools, we streamline the path to market access. Our services include developing regulatory strategies, acting as your in-country representative, and using AI to efficiently compile technical dossiers for submission. Let us help you turn regulatory hurdles into market opportunities. Contact us at [email protected], visit our website at https://pureglobal.com, or explore our free AI tools and database at https://pureglobal.ai to accelerate your global expansion.